TickerFacts.

BioNexus Gene Lab Corp (BGLC): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2022-12-31, 2023-12-31, 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.84M
Year ended 2025-12-31
-$846.6K
Trailing 12 months to 2026-06-30
$552.7K2018-12-31: -$274.1K2019-12-31: -$217.3K2020-12-31: $552.7K2021-12-31: $9.2K2022-12-31: $551.8K2023-12-31: -$1.82M2024-12-31: -$2.09M2025-12-31: -$1.84M-$1.84M
2018-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$1.84Mn/m2026-04-14, From 2025-01-01
2024-12-31-$2.09Mn/c2026-04-14, From 2024-01-01
2023-12-31-$1.82Mn/c2025-04-15, From 2023-01-01
2022-12-31$551.8Kn/c2024-04-16, From 2022-01-01
2021-12-31$9.2K-98.3%2023-03-31, From 2021-01-01
2020-12-31$552.7Kn/m2022-04-06, From 2020-01-01
2019-12-31-$217.3Kn/m2021-03-30, From 2019-01-01
2018-12-31-$274.1Kn/a2020-03-31, From 2018-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
BioNexus Gene Lab Corp (BGLC)2025-12-31-$1.84Mn/m
American Shared Hospital Services (AMS)2025-12-31$3.10Mn/m
CapForce Inc. (CFOR)2025-12-31-$1.18Mn/m
Exagen Inc. (XGN)2025-12-31-$13.62Mn/m
Personalis, Inc. (PSNL)2025-12-31-$74.95Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.27Mn/m
YD Bio Ltd (YDES)2025-12-31-$6.60Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.01Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$24.59Mn/m

Compare BGLC, AMS, CFOR, XGN side by side · Screen every company in Services-Medical Laboratories ↗